About PROCEPT BioRobotics
PROCEPT BioRobotics is a publicly listed company based in Redwood City (United States) founded in 2009. Robotic waterjet system for prostate tissue removal is developed. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. PROCEPT BioRobotics has raised $348.84 million across 8 funding rounds from investors including Fidelity Investments, T. Rowe Price and Perceptive Advisors. The company has 756 employees. Its chief executive, as recorded, is Reza Zadno. Its website procept-biorobotics.com draws about 19 thousand monthly visits. PROCEPT BioRobotics offers products and services including Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System. Its focus areas include Life Sciences, Surgical Instruments, Robotic Surgery and High Tech. Its legal entity is PROCEPT BioRobotics Corporation. Its competitors include Intuitive, Auris Health and Corindus Vascular Robotics; 3 of its 3 listed competitors have raised funding.
Company details
PROCEPT BioRobotics was founded in 2009 in Redwood City, United States, within the medical device sector focused on urology. An image-guided robotic platform is developed for treating benign prostatic hyperplasia through targeted prostate tissue resection. Real-time ultrasonic guidance is utilized for surgical planning and controlled delivery of high-velocity saline streams, enabling personalized procedures in outpatient settings.
- Headquarters Redwood City, United States
- Employees 756
- Stage Public
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website procept-biorobotics.com
- Social LinkedIn X Facebook
- Legal Name Procept Biorobotics Corporation
- Annual Revenue$308.05 M (USD)37.22as on Dec 31, 2025
- Net Profit-$95.57 M (USD)-4.55as on Dec 31, 2025
- EBITDA-$97.47 M (USD)-6.66as on Dec 31, 2025
- Total Equity Funding$348.84M (USD)
in 8 rounds
- Latest Funding Round$172.5M (USD), Post-IPO
Sep 2023
- InvestorsFidelity Investments
& 5 more
- Employee Count756
Products & Services of PROCEPT BioRobotics
PROCEPT BioRobotics offers a comprehensive portfolio of products and services, including Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System.
Ultrasound-guided robotic treatment for benign prostatic hyperplasia.
AI-powered platform for precise BPH therapy procedures.
Waterjet-based system for prostate tissue resection.
Funding Insights of PROCEPT BioRobotics
PROCEPT BioRobotics has successfully raised a total of $348.84M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $172.5 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $348.84M
- Total Rounds 8
- Last Round Post-IPO — $172.5M
- First Round $6.05M
(Oct 2013)
- Investors Count 6
All 8 funding rounds of PROCEPT BioRobotics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $172.5M | Post-IPO | – | – | – |
| Jun 2021 | $85M | Series G | – | Fidelity Investments | |
| Aug 2020 | $76.98M | Series C | – | – | – |
| Feb 2018 | $118M | Series C | – | Viking Global Investors | |
| Aug 2017 | $13.14M | Series B | – | – | – |
| Jul 2015 | $42M | Series B | – | Novo Holdings | |
| Aug 2014 | $7.67M | Series A | – | – | – |
| Oct 2013 | $6.05M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in PROCEPT BioRobotics
PROCEPT BioRobotics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investment firm focused on multiple sectors | vikingglobal.com | Greenwich, United States | ||
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States | |
Software solutions for mainframe platforms are provided by the company. | 1993 | cpmg.com | Montague, United States |
Investor details for PROCEPT BioRobotics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PROCEPT BioRobotics
331 people are tracked at PROCEPT BioRobotics (50 in leadership, 7 in board & advisors, 274 in team); the tracked headcount is 756.
| Name | Role | Group |
|---|---|---|
Reza Zadno | CEO & President | Leadership |
Mark Buckley | Sales Director, UK & Ireland | Leadership |
David Villarreal | Sr. Director Of Operations Engineering | Leadership |
Sammy Lee | Head Of Fp&a | Leadership |
Kathy van Hoy | Senior Director, QA Ops, Disposables & Accessories | Leadership |
Drew Zenger | Sr Director Product Engrg R D | Leadership |
Matthew Young | Vice President, Product Management And Marketing | Leadership |
Jeff Gellman | Western US Capital Director Urology Robotics | Leadership |
Lisa Gildea | Vice President Of Sales, US | Leadership |
Kyle Kelch | Vice President, US Sales | Leadership |
Lindsey Fujita | Vice President, Commercial Strategy & Operations | Leadership |
Eleonora Manuel | Vice President, Talent Rewards, Analytics, And Systems | Leadership |
Todd Radgowski | Vice President PMO And Systems Engineering | Leadership |
Alireza Y. | Director Program Management | Leadership |
Alaleh Nouri | EVP, Chief Legal Officer | Leadership |
Samantha Presley | Sr. Director Global Learning And Development | Leadership |
Stephanie Tawn | Senior Director, People Operations | Leadership |
Kevin Waters | EVP, CFO | Leadership |
Stacey Porter | Chief People Officer (we're Hiring!) | Leadership |
Charlie Wiggins | Director US Commercial Marketing & Medical Education | Leadership |
311 more people are available in the full profile.
Complete people profiles for PROCEPT BioRobotics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PROCEPT BioRobotics
PROCEPT BioRobotics is a publicly listed company on the NASDAQ with ticker symbol PRCT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Sep 2021
- Listed onNASDAQ: PRCT
- Listed entityPROCEPT BioRobotics Corporation
- Exchange sectorHealth technology
- ISINUS74276L1052
- Share price$19.10 (-2.4% on the day) · 2026-10-13
- Market capitalisation$1.09B
- EPS (diluted, trailing year)$-1.95
- Volume (last session)1,814,715
Financials of PROCEPT BioRobotics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $308.1M | -$95.6M | -$97.5M |
| 2024 | $224.5M | -$91.4M | -$91.4M |
| 2023 | $136.2M | -$105.9M | -$105.4M |
| 2022 | $75.0M | -$87.2M | -$76.4M |
| 2021 | $34.5M | -$59.9M | -$51.2M |
Detailed financial statements for PROCEPT BioRobotics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PROCEPT BioRobotics
4 dated milestones of PROCEPT BioRobotics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded PROCEPT BioRobotics is founded.
- Funding First funding round of $6.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $172.5M.
Competitors of PROCEPT BioRobotics
PROCEPT BioRobotics has 3 listed competitors in our database, 3 of them funded. They include Intuitive, Auris Health and Corindus Vascular Robotics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| intuitive.com | 1995 | Sunnyvale, United States | $17M | 15 | Robotic-assisted surgical systems are developed for minimally invasive procedures. | |
| aurishealth.com | 2007 | Redwood, United States | $733.62M | 242 | Robotic microsurgical systems for endoscopy are developed. | |
| corindus.com | 2001 | Waltham, United States | $21.91M | 170 | Remote robotic systems for vascular interventional procedures are developed. |
Detailed competitors of PROCEPT BioRobotics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PROCEPT BioRobotics
The website of PROCEPT BioRobotics (procept-biorobotics.com) receives about 18.9K visits a month.
- Monthly visits18.9K
▼ 1.9% vs previous month
Websites whose visitors overlap most with PROCEPT BioRobotics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| massdevice.com | 100% | #435,992 | View details | ||
emjreviews.com | emjreviews.com | 59% | #215,870 | – | |
mail.google.com | mail.google.com | 42% | – |
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as PROCEPT BioRobotics (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 | ||
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Procept Biorobotics
Complete news archive for PROCEPT BioRobotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PROCEPT BioRobotics
PROCEPT BioRobotics was founded in 2009 and raised its 1st funding round 4 years after it was founded.
PROCEPT BioRobotics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Reza Zadno is the CEO of PROCEPT BioRobotics, as recorded in our data.
PROCEPT BioRobotics is a funded company, having raised a total of $348.84M across 8 funding rounds to date. The company's 1st funding round was a Series A of $6.05M, raised on Oct 2013.
PROCEPT BioRobotics has 756 employees.
Annual revenue of PROCEPT BioRobotics is $308.05M as on Dec 31, 2025.
PROCEPT BioRobotics was founded in 2009 in Redwood City, United States, within the medical device sector focused on urology. An image-guided robotic platform is developed for treating benign prostatic hyperplasia through targeted prostate tissue resection. Real-time ultrasonic guidance is utilized for surgical planning and controlled delivery of high-velocity saline streams, enabling personalized procedures in outpatient settings.
PROCEPT BioRobotics's top competitors include Auris Health, Corindus Vascular Robotics and Intuitive.
PROCEPT BioRobotics offers Aquablation Therapy, HYDROS Robotic System, and AquaBeam Robotic System.
Yes, PROCEPT BioRobotics is publicly traded on NASDAQ under the ticker symbol PRCT.
PROCEPT BioRobotics has 6 investors. Key investors include Fidelity Investments, T. Rowe Price, Perceptive Advisors, Computer Programs Marketing Group, and Viking Global Investors.
PROCEPT BioRobotics operates through Procept Biorobotics Corporation.